Disease Burden of Total and Early-Onset Colorectal Cancer in China from 1990 to 2019 and Predictions of Cancer Incidence and Mortality
DOI: https://doi.org/10.2147/CLEP.S391058
2023-02-01
Clinical Epidemiology
Abstract:Bule Shao, 1, 2, &ast Mengjia Zhu, 1, &ast Kai Shen, 1, 2 Liang Luo, 1, 2 Ping Du, 1, 2 Jun Li, 1, 2 Jing Xu, 3 Yanyong Deng, 1, 2 Ne Lin, 1, 2 Jiaguo Wu, 1, 2 Weiling Hu 1, 2, 4 1 Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 2 Institute of Gastroenterology, Zhejiang University, Hangzhou, People's Republic of China; 3 Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 4 Cancer Center, Zhejiang University, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jiaguo Wu; Weiling Hu, Email ; Background: Understanding the temporal trends in the epidemiology of colorectal cancer (CRC) and early-onset CRC (EOCRC) in China is essential for policymakers to develop appropriate strategies to reduce the CRC burden. Methods: The prevalence, incidence, mortality, years of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life years (DALYs) of CRC were obtained from the Global Burden of Disease (GBD) Study 2019. The incidence and mortality of CRC over the next 25 years were predicted. Results: From 1990 to 2019, the prevalence, incidence, and mortality of total CRC and EOCRC significantly increased in males, with milder trends in females. In 2019, the number of people living with CRC (or EOCRC) in China was approximately 3.4 (0.59) million, which was over seven (five) times higher than that in 1990. The DALYs, YLDs, and YLLs moderately increased from 1990 to 2019 in both sexes. The age-standardized mortality rate (ASMR) for females has shown a stable trend in total CRC, and a downward trend in EOCRC since 2000. While the ASMR for males showed increasing trends in total CRC and EOCRC. In 2019, the highest incidence, prevalence, YLDs, YLLs, and DALYs were all observed in the 65 to 69 age group, while the highest mortality was in the 70 to 74. By 2044, the incidence and deaths of CRC are expected to reach 1310 thousand and 484 thousand, respectively. For EOCRC, the incidence will peak at about 101 thousand around 2034, and the mortality will continuously decrease to a nadir at about 18 thousand around 2044. Conclusion: Although the age-standardized incidence and mortality of total CRC and EOCRC in China will reach a plateau, the number of incident cases and deaths of CRC have been increasing in the last three decades and will continue to increase in the next 25 years. Graphical Keywords: early-onset colorectal cancer, prevalence, incidence, mortality, disability-adjusted life years, age-period-cohort analysis Graphical The incidence and mortality of colorectal cancer (CRC) are rising rapidly worldwide. CRC is becoming the third most common cancer and the second leading cause of cancer-related deaths. 1 It is estimated that there will be over 1.9 million newly diagnosed CRC patients and nearly one million CRC-related deaths in 2020 globally, accounting for approximately one-tenth of cancer cases and deaths. 1 The burden of CRC is also crucial in China, ranking as the fourth leading cause of cancer-related deaths. 3 The interest in early-onset CRC (EOCRC) has been increasing, which is defined as CRC that occurs under the age of 50 years. A previous study conducted in nine high-income countries found that the incidence of EOCRC was increasing. 2 A recent study showed that the incidence and mortality of CRC had decreased in some European and North American countries. However, the burden of CRC and EOCRC continues to increase in many low- and middle-income countries, including China. 4 Nearly 70% of all deaths worldwide are caused by noncommunicable diseases, including heart disease, stroke, cancer, diabetes, and chronic lung disease. 5 It is estimated that 75% of the deaths are caused by noncommunicable diseases and 82% of the premature deaths (before 70 years of age) occur in low- and middle-income countries. 5 The disease spectrum in China has gradually shifted from communicable to noncommunicable diseases with China's rapid economic development. 6 A stable or decreasing temporal trend of the incidence and mortality rates of CRC is observed in highly developed countries. However, the trend of CRC has been rising rapidly in China. 7 The growing incidence of CRC in low- and m -Abstract Truncated-
public, environmental & occupational health